Immunology of the myelodysplastic syndromes

The Myelodysplastic Syndromes: Pathobiology and Clinical Management

Volumn , Issue , 2002, Pages 65-88

  Hamblin, Terry J ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041477078     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (117)

1. Hamblin TJ. Immunological abnormalities in MDS. In: Galton DAG, Mufti GJ, eds. The Myelodysplastic Syndromes. Edinburgh: Churchill Livingstone, 1991:97-114.
2. Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6:571-586.
3. Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes (review). Semin Hematol 1996; 33:150-162.
4. Aomatsu I, Isano K, Iizuka S, Mori T, Ohara HM, Ishii Y. A case of tuberculous uveitis complicated by myelodysplastic syndrome. Nippon Ganka Gakkai Zasshi 2000; 104:183-188 [Japanese].
5. Satomi A, Nagai S, Nagai T, Niikura K, Ideura T, Ogata H, Akizaw T. Effect of plasma exchange on refractory hemophagocytic syndrome complicated with myelodysplastic syndrome. Ther Apher 1999; 3:317-319.
6. Kuwahara Y, Hirata A, Miwa H, Munakata S, Ueda S, Kanakura Y, Maruno M, Hongyo T, Nomura T, Aozasa K. Epstein-Barr virus associated B-cell lymphoma of brain developing in myelodysplastic syndrome with c-kit mutation (Tyr-577 stop). Am J Hematol 2000; 65:234-238.
7. Yetgin S, Cetin M, Yenicesu I, Ozaltin F, Uckan D. Acute parvovirus B19 infection mimicking juvenile myelomonocytic leukemia. Eur J Haematol 2000; 65:276-278.
8. Raza A. Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus. Med Oncol 1998; 15:165-173.
9. Mundle S, Allampallam K, Aftab Rashid K, Dangerfield B, Cartlidge J, Zeitler D, Afenya E, Alvi S, Shetty V, Venugopal P, Raza A. Presence of activation-related m-RNA for EBV and CMV in the bone marrow of patients with myelodysplastic syndromes. Cancer Lett 2001; 164:197-205.
10. Karlic H, Mostl M, Mucke H, Pavlova B, Pfeilstocker M, Heinz R. Association of human T-cell leukemia virus and myelodysplastic syndrome in a central European population. Cancer Res 1997; 57:4718-4721.
11. Mufti GJ, Figes A, Hamblin TJ, Oscier DG, Copplestone JA. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol 1986; 63:143-147.
12. Dreyfus B, Vernant JP, Wechsler J, Imbert M, de Pprost Y, Reyes F, Sobel A, Rochant H, Galacteros F, Farcet JP. Anemie refractaire avec exces de myeloblastes et vascularite cutanee. Nouv Rev Fr Hematol 1981; 21:115-121.
13. Lopez FF, Vaidyan PB, Mega AE, Schiffman FJ. Aortitis as a manifestation of myelodysplastic syndrome. Postgrad Med J 2001; 77:116-118.
14. Aractingi S, Bachmeyer C, Dombret H, Vignon-Pennamen D, Degos L, Dubertret L. Simultaneous occurrence of two rare cutaneous markers of poor prognosis in myelodysplastic syndrome: erythema elevatum diutinum and specific lesions (review). Br J Dermatol 1994; 113:112-117.
15. Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations of hematologic malignancies (review). Am J Med 1995; 99:207-216.
16. Sweet RD. Acute febrile neutrophilic dermatosis—1978. Br J Dermatol 1979; 100: 93-99.
17. Krolikowski FJ, Reuter K, Shultis EW. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) associated with lymphoma. Hum Pathol 1985; 16:520-522.
18. Lazarus AA, McMillan M, Miramadi A. Pulmonary involvement in Sweet’s syndrome (acute febrile neutrophilic dermatosis). Preleukemic and leukemic phases of acute myelogenous leukaemia. Chest 1986; 90:922-924.
19. Marie I, Levesque H, Joly P, Reumont G, Courville P, Baudrimont M, Baubion D, Cailleux N, Courtois H. Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol 2001; 44:137-139.
20. Rouhiainen HJ. Orbital inflammation as a presenting sign for myelodysplastic syndrome. Acta Ophthalmol (Copenh) 1989; 67:109-111.
21. Shimizu K. Neutrophilic infiltration of the myocardium in a patient with myelodysplastic syndrome. Am J Hematol 1998; 58:337-338.
22. Avivi I, Rosenbaum H, Levy Y, Rowe J. Myelodysplastic syndrome and associated skin lesions: a review of the literature (review). Leuk Res 1999; 23:323-330.
23. DasGupta R, Fairham SA, Womack C, Burton C, Sivakumaran M. An unusual cutaneous manifestation of myelodysplastic syndrome: ‘pseudo-Koebner phenomenon.’ J Clin Pathol 1998; 51:860-861.
24. Grune S, Panizzon R, Egli F, Siegenthaler W, Greminger P. The appearance of Sweet’s syndrome during the transition from a myelodysplastic syndrome to eryth-roleukemia (review). Dtsch Med Wochenschr 1996; 121:939-942 [German].
25. Arbetter KR, Hubbard KW, Markovic SN, Gibson LE, Phyliky RL. Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol 1999; 61:126-129.
26. Equitani F, Mele L, Rutella S, Belli P, Paciaroni K, Piscitelli R, Pagano L. Atypical Sweet’s syndrome in a neutropenic patient with acute myeloid leukemia, secondary to RAEB-T, simulating thrombophlebitis. Panminerva Med 1999; 41:261-263.
27. Megarbane B, Bodemer C, Valensi F, Radford-Weiss I, Fraitag S, MacIntyre E, Bletry O, Varet B, Hermine O. Association of acute neutrophilic dermatosis and myelodysplastic syndrome with (6;9) chromosome translocation: a case report and review of the literature (review). Br J Dermatol 2000; 143:1322-1324.
28. Watari K, Tojo A, Ngamura-Inoue T, Matsuoka M, Irie S, Tani K, Yamada Y, Asano S. Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia: a case report with in vitro studies. Cancer 2000; 89:551-560.
29. Zappasodi P, Corso A, del Forno C. Sweet’s syndrome and myelodysplasia: two entities with a common pathogenetic mechanism? A case report. Haematologica 2000; 85:868-869.
30. Tomasini C, Aloi F, Osella-Abate S, Dapavo P, Pippione M. Immature myeloid precursors in chronic neutrophilic dermatosis associated with myelodysplastic syndrome. Am J Dermatopathol 2000; 22:429-433.
31. Keoster G, Tarnower A, Levisohn D, Burgdorf W. Bullous pyoderma gangrenosum (review). J Am Acad Dermatol 1993; 29:875-878.
32. Reuss-Borst MA, Pawelec G, Saal JG, Horny HP, Muller CA, Waller HD. Sweet’s syndrome associated with myelodysplasia: a possible role of cytokines in the pathogenesis of the disease. Br J Haematol 1993; 84:356-358.
33. Quiepo de Llano MP, Yerba M, Cabrera R, Suarez E. Myelodysplastic syndrome in association erythema elevatum diutinum. J Rheumatol 1992; 19:1005-1006.
34. Katz SI, Gallin JL, Hertz KC, Fauci AS, Lawley TS. Erythema elevatum diutinum: skin and systemic manifestations, immunologic studies and successful treatment with dapsone. Medicine (Baltimore) 1977; 56:443-455.
35. Ohno E, Ohtsuka E, Watanabe K, Kohono T, Takeoka K, Saburi Y, Kikuchi H, Nasu M. Behcet’s disease associated with myelodysplastic syndromes. A case report and review of the literature (review). Cancer 1997; 79:262-268.
36. Oh EJ, Yoon JS, Park YJ, Cho CS, Kim BK. Behcet’s disease associated with myelodysplastic syndrome: a case report. J Korean Med Sci 1999; 14:685-687.
37. Della Rossa A, Tavoni A, Tognetti A, Testi C, Bombardieri S. Behcet’s disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism. Clin Rheumatol 1998; 17:515-517.
38. Tanaka E. Nishinarita M, Uesato M, Kamatani N. A case of intestinal Behcet’s disease with abnormal ossification complicated by myelodysplastic syndrome, symptoms revealed after the perforation of ileum ulcer (review). Ryumachi 2000; 40:711-718 [Japanese].
39. Billstrom R, Johansson H, Johansson B, Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes—clinical and cytogenetic features. Eur J Haematol 1995; 55:42-48.
40. Hebbar M, Brouillard M, Wattel E, Decoulx M, Hatron PY, Devulder B, Fenaux P. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence (review). Leukemia 1995; 9:731-733.
41. Loeffler KU, McLean IW. Bilateral necrotizing scleritis and blindness in the myelodysplastic syndrome presumably due to relapsing polychondritis. Acta Ophthalmol Scand 2000; 78:228-231.
42. Diebold L, Rauh G, Jager K, Lohrs U. Bone marrow pathology in relapsing polychondritis: high frequency of myelodysplastic syndromes. Br J Haematol 1995; 89: 820-830.
43. Hall R, Hopkinson N, Hamblin TJ. Relapsing polychondritis, smouldering nonse-cretory myeloma and early myelodysplastic syndrome in the same patient: three difficult diagnoses produce a life threatening illness. Leuk Res 2000; 24:91-93.
44. Pirayesh A, Verbunt RJ, Kluin PM, Meinders AE, De Meijer PH. Myelodysplastic syndrome with vasculitic manifestations (review). J Intern Med 1997; 242:425-431.
45. Maeda Y, Arakawa K, Araki E, Kikuchi H, Ikezoe K, Taniwaki T, Kira J. Polymyositis and cutaneous vasculitis in a patient with myelodysplastic syndrome. Rinsho Shinkeigaku 1999; 39:639-642 [Japanese].
46. Chandran G, Ahern MJ, Seshadri P, Coghlan D. Rheumatic manifestations of the myelodysplastic syndrome: a comparative study. Aust NZ J Med 1996; 26:683-688.
47. George SW, Newman ED. Seronegative inflammatory arthritis in the myelodysplastic syndromes (review). Semin Arthritis Rheum 1992; 21:345-354.
48. Hisakawa N, Nishiya K, Hashimoto K, Tanaka Y. A case of malignant rheumatoid arthritis associated with myelodysplastic syndrome (review). Ryumachi 1997; 37: 30-35 [Japanese].
49. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995; 91:403-408.
50. Scully RE, Mark EJ, McNely WF, Ebeling SH, Phillips LD. Case records of the Massachusetts General Hospital Case 5-1998. N Engl J Med 1998; 338:453-461.
51. Matsushima T, Murakami H, Kim K, Uchiumi H, Murata N, Tamura J, Sawamura M, Karasawa M, Naruse T, Tsuchiya J. Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der(1q;7p) chromosomal abnormality. Am J Hematol 1995; 50:110-115.
52. Saito T, Murakami H, Uchiumi H, Moridaira K, Maehara T, Matsushima T, Tsuka-moto N, Tamura J, Karasawa M, Naruse T, Tsuchiya J. Myelodysplastic syndromes with nephritic syndrome. Am J Hematol 1999; 60:200-204.
53. Komatsuda A, Miura I, Ohtani H, Hamai K, Wakui H, Imai H, Kobayashi Y, Miura A. Crescentic glomerulonephritis accompanied by myeloperoxidase antineutrophil cytoplasmic antibodies in a patient having myelodysplastic syndrome with trisomy 7. Am J Kidney Dis 1998; 31:336-340.
54. Hamidou MA, Derenne S, Audrain MA, Berthelot JM, Boumalassa A, Grolleau JY. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study. Rheumatology (Oxford) 2000; 39:417-420.
55. Komiya I, Tanoue K, Kakinuma K, Kaneda M, Shinohara T, Kuriya S, Nomura T, Saito Y. Superoxide anion hyperproduction by neutrophils in a case of myelodysplastic syndrome. Association with Sweet’s syndrome and interstitial pneumonia. Cancer 1991; 67:2337-2341.
56. Matsumura T, Kami M. Sweet’s syndrome after granulocyte colony-stimulating factor administration for refractory myelodysplastic syndrome. Medical Images. Br J Haematol 2001; 113:1.
57. Kawabata H, Utsunomiya A, Hanada S, Makino T, Takatsuka Y, Takeuchi S, Suzuki S, Suzumiya J, Ohshima K, Horiike S. Myelodysplastic syndrome in a patient with adult T-cell leukaemia. Br J Haematol 1999; 106:702-705.
58. Saunthararajah Y, Molldrem JL, Rivera M, Williams A, Stetler-Stevenson M, Sorbara L, Young NS, Barrett JA. Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001; 112:195-200.
59. Lorand-Metze I, Lima CS, Cardinalli IA, Vassallo J. Association of a myelodysplastic syndrome with hairy cell leukaemia. Eur J Haematol 1995; 55:341-343.
60. Bassan R, Marini B, Allavena P, Pirelli A, Barbui T. RAEB in a patient with chronic granulated T-lymphocytosis. Br J Haematol 1987; 65:503-504.
61. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood 1994; 84:1620-1627.
62. Molldrem JJ, Jiang YZ, Stetler-Stevenson M, Mavroudis D, Hensel N, Barrett JA. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor V beta profiles. Br J Haematol 1998; 102: 1314-1322.
63. Luraschi A, Saglietti G, Fedeli P, Gioria A, Della Vedova A, Ferrari V, Borgotti P. Immunological indices in myelodysplastic syndromes. Minerva Med 1994; 85: 145-153 [Italian].
64. Srivannaboon K, Conley ME, Coustan-Smith E, Wang WC. Hypogammaglobulinemia and reduced numbers of B-cells in children with myelodysplastic syndrome. Am J Pedriatr Hematol Oncol 2001; 23:122-125.
65. Katsuki K, Shinohara K, Kameda N, Yamada T, Takeda K, Kamei T. Two cases of myelodysplastic syndrome with extramedullary polyclonal plasma cell proliferation and autoantibody production: possible role of soluble Fas antigen for production of excessive self-reactive B cells. Intern Med 1998; 37:973-977.
66. Stahl D, Egerer G, Goldschmidt H, Sibrowski W, Kazatchkine MD, Kaveri SV. Altered self-reactive antibody repertoires are a general feature of patients with myelodysplastic syndrome. J Autoimmune Dis 2001; 16:77-86.
67. Hilbe W, Eisterer W, Schmid C, Starz I, Silly H, Duba C, Ludescher C, Thaler J. Bone marrow lymphocyte subsets in myelodysplastic syndromes. J Clin Pathol 1994; 47:505-507.
68. Tsuda H, Yamasaki H. Type I and type II T-cell profiles in aplastic anemia and refractory anemia. Am J Hematol 2000; 64:271-274.
69. Yokose N, Ogata K, Ito T, An E, Tamura H, Dan K, Hamaguchi H, Sakamaki H, Onozawa Y, Nomura T. Elevated plasma soluble interleukin-2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromes. Leuk Res 1994; 18:777-782.
70. Tsuchida T, Sakane T, Ishikura H, Tsunematsu T. Impairment of lymphocyte function in patients with myelodysplastic syndrome and its correction by addition of Ca2+ ionophore and phorbol myristate acetate. Int J Hematol 1991; 54:505-513.
71. Baumann MA, Milson TJ, Patrick CW, Libnoch JA, Keller RH. Immunoregulatory abnormalities in myelodysplastic disorders. Am J Hematol 1986; 22:17-26.
72. Thiele J, Romatowski C, Wagner S, Dienemann D, Stein H, Fischer R, Falini B. Macrophages (phagocytic-histiocytic reticular cells) in reactive-inflammatory lesions in the bone marrow and in myelodysplastic syndromes (MDS). Pathol Res Pract 1992; 188:995-1001.
73. Kitagawa M, Kamiyama R, Kasuga T. Increase in number of bone marrow macrophages in patients with myelodysplastic syndromes. Eur J Haematol 1993; 51:56-58.
74. Rigolin GM, Cuneo A, Roberti MG, Bardi A, Castoldi G. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization. Haematologica 1997; 82:25-30.
75. Ohmori M, Ohmori S, Ueda Y, Tohyama K, Yoshida Y, Uchino H. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells. Br J Haematol 1990; 74:179-184.
76. Zoumbos N, Symeonidis A, Kourakli A, Katevas P, Matsouka P, Peraki M, Geor-goulias V. Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes. Blood 1991; 77:413414.
77. Kitagawa M, Saito I, Yoshida S, Yamaguchi S, Takahashi M, Tanizawa I, Kami-yama R, Hirokawa K. Overexpression of tumor necrosis factor (TNF) alpha and interferon (IFN) gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia 1997; 11:2049-2054.
78. Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, Borok R, Showel J, Gregory S, Rifkin S, Gezer S, Parcharidou A, Venugopal P, Shah R, Hernandez B, Klein M, Alston V, Robin E, Dominque C, Raza A. Measurement of apoptosis proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 1996; 20:891-900.
79. Verhoef GE, De Schouwer P, Ceuppens JL, Van Damme J, Goossens W, Boogaerts MA. Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 1992; 6:1268-1272.
80. Mencoboni M, Castello G, Lerza R, Haupt R, Ballarino P, Cerruti A, Bogliolo G, Pannacciulli I. Production of tumor necrosis factor and granulocyte colony stimulating factor by bone marrow accessory cells in myelodysplastic patients. Eur J Haematol 1996; 56:148-152.
81. Matteo Rigolin G, Howard J, Buggins A, Sneddon C, Castoldi G, Hirst WJ, Mufti GJ. Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes. Br J Haematol 1999; 107:844-850.
82. Kyriakou D, Liapi D, Kyriakou E, Alexandrakis M, Vlachonikolis IG, Mavroma-manolakis M, Eliakis P, Eliopoulos GD. Aberrant expression of the major sialogly-coprotein (CD43) on the monocytes of patients with myelodysplastic syndromes. Ann Hematol 2000; 79:198-205.
83. Pajor L, Matolcsy A, Vass JA, Mehes G, Marton E, Szabo F, Ivanyi JL. Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome. Leuk Res 1998; 22:13-17.
84. Abruzzese E, Buss D, Rainer R, Pettenati MJ, Rao PN. Progression of a myelodys-plastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Ann Hematol 1966; 73:35-38.
85. Lima CS, deSouza CA, Cardinalli IA, Lorand-Metze I. Lymphoblastic transformation of myelodysplastic syndrome. Rev Paul Med 1997; 115:1508-1512.
86. Lau RC, Squire J, Brisson L, Kamel-Ried S, Grunberger T, Dube I, Letarte M, Shannon K, Freedman MH. Lymphoid blast crisis of a B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML). Leukemia 1994; 8:903-908.
87. Yamamoto M, Nakagawa M, Ichimura N, Ohtsuki F, Ohtsuka Y, Tsujino Y, Tanaka A, Kamiya T, Wada H. Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant. Am J Hematol 1996; 52:212-214.
88. Kouides PA, Bennett JM. Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome (review). Am J Hematol 1995; 49:157-162.
89. Kohno T, Amenomori T, Atogami S, Sasagawa I, Nakamura H, Kuriyama K, To-monaga M. Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript. Br J Haematol 1996; 93:389-391.
90. Leseve JF, Troussard X, Bastard C, Hurst JP, Nouet D, Callat MP, Lenormand B, Piguet H, Flandrin G, Macintyre E. p190bcr/abl rearrangement in myelodysplastic syndromes: two reports and review of the literature (review). Br J Haematol 1996; 95:372-375.
91. Escudier SM, Albitar M, Robertson LE, Andereef M, Pierce S, Kantarjian HM. Acute lymphoblastic leukemia following preleukemic syndromes in adults. Leukemia 1996; 10:473-477.
92. Prchal JT, Throckmorton DW, Carroll AJ III, Fuson EW, Gams RA, Prchal JF A common progenitor for human myeloid and lymphoid cells. Nature 1978; 274:590-591.
93. Raskind WH, Tirumali N, Jacobson R, Singer J, Fialkow PJ. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984; 63:1318-1323.
94. Okamoto T, Okada M, Itoh T, Mori A, Saheki K, Takatsuka H, Wada H, Tamura A, Fujimori Y, Takemoto Y, Kanamaru A, Kakishita E. Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation. Int J Hematol 1998; 68:61-65.
95. Okada M, Okamoto T, Takemoto Y, Kanamaru A, Kakishita E. Function and X chromosome inactivation analysis of B lymphocytes in myelodysplastic syndromes with immunological abnormalities. Acta Haematol 2000; 102:124-130.
96. Soenen V, Fenaux P, Flactif M, Lepelley P, Lai JL, Cosson A, Predhomme C. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes. Br J Haematol 1995; 90:701-706.
97. Abruzzese E, Buss D, Rainer R, Rao PN, Pettenati MJ. Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridisation. Leuk Res 1996; 20:551-557.
98. Fugazza G, Lerza R, Bruzzone R, Sessarego M. Clonality study by fluorescence in situ hybridisation of a patient with refractory anemia with ringed sideroblasts and monosomy 7. Haematologica 1995; 80:54-57.
99. Jaju RJ, Jones M, Boultwood J, Kelly S, Mason DY, Wainscoat JS, Kearney L. Combined immunophenotyping and FISH identifies the involvement of B-cells in the 5q-syndrome. Genes Chromosomes Cancer 2000; 29:276-280.
100. van Lom K, Hagemeijer A, Smit E, Hahlen K, Groeneveld K, Lowenberg B. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and lymphoid lineage. Leukemia 1995; 9:1818-1821.
101. Billstrom R, Johansson B, Strombeck B, el-Rifai W, Larramendy M, Olofsson T, Mitelman F, Knuutila S. Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8. Ann Hematol 1997; 74:37-40.
102. Mongkonsritragoon W, Letendre L, Li CY. Multiple lymphoid nodules in bone marrow have the same clonality as underlying myelodysplastic syndrome recognized with fluorescent in situ hybridisation technique. Am J Hematol 1998; 59: 252-257.
103. Miura I, Kobayashi Y, Takahashi N, Saitoh K, Miura AB. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescent in situ hybridization to cells collected by means of fluorescence-activated cell sorting. Br J Haematol 2000; 110:876-879.
104. Cooper LJ, Shannon KM, Loken MR, Weaver M, Stephens K, Sievers EL. Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell. Blood 2000; 96:2310-2313.
105. Tichelli A, Gratwohl A, Wuersch A, Nissen C, Speck B. Antilymphocyte globulin for myelodysplastic syndrome. Br J Haematol 1988; 68:139-140.
106. Litzow MR, Kyle RA. Multiple responses of aplastic anemia to low-dose cyclosporine therapy despite development of a myelodysplastic syndrome. Am J Hematol 1989; 32:226-229.
107. Motoji T, Teramura M, Takahashi M, Oshimi K, Okada M, Kusakabe K, Mizoguchi H. Successful treatment of refractory anemia with high-dose methylprednisolone. Am J Hematol 1990; 33:8-12.
108. Muller EW, de Wolf JT, Vellenga E. Successful immunosuppressive treatment after failure of erythropoietin therapy in two subjects with refractory anaemia. Br J Haematol 1993; 83:171-172.
109. Biesma DH, van den Tweel JG, Verdonck LF. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer 1997; 79:1548-1551.
110. Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ. Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 1997; 99:699-705.
111. Jonasova A, Neuwirtova R, Cermak J, Vozobulova V, Mocikova K, Siskova M, Hochova I. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998; 100:304-309.
112. Berer A, Ohler L, Simonitsch I, Thalhammer R, Lechner K, Geissler K. Longterm improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome. Wien Klin Wochenschr 1999; 111:815-818.
113. Samuelsson J, Larfars G. Unusual clinical presentation in a patient with myelodys-plastic syndrome, with subsequent haematological remission and suppression of malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor. Leuk Res 1999; 23:513-517.
114. Takanashi M, Kadono Y, Tabata Y, Hibi S. Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome. Rinsho Ketsueki 1999; 40:1093-1099 [Japanese].
115. Catalano L, Selleri C, Califano C, Luciano L, Volpicelli M, Rocco S, Varriale G, Ricci P, Rotoli B. Prolonged response to cyclosporin-A in hypoplastic anemia and correlation with in vitro studies. Haematologica 2000; 85:133-138.
116. Killick SB, Marsh JC, Gordon-Smith EC, Sorlin L, Gibson FM. Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia. Br J Haematol 2000; 108:582-591.
117. Jarrett O, Onions DE. Retroviruses in leukaemia of animals. In: Goldman JM, Preisler HD, eds. Butterworths’ International Medical Reviews of Haematology. I. Leukaemias. London: Butterworths, 1984:1-34.